Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae

Developmental Medicine and Child Neurology

Volumn 59, Issue 8, 2017, Pages 806-814

  Kothur, Kavitha ^a   Gill, Deepak ^b   Wong, Melanie ^b   Mohammad, Shekeeb S ^a   Bandodkar, Sushil ^b   Arbunckle, Susan ^a   Wienholt, Louise ^c   Dale, Russell C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALIMEMAZINE; ALPHA INTERFERON; APRIL PROTEIN; CD163 ANTIGEN; CD20 ANTIBODY; CD4 ANTIBODY; CD8 ANTIGEN; CHEMOKINE; CHLORAL HYDRATE; CLONIDINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; DEXMEDETOMIDINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN; INTERLEUKIN 13; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; METHYLPREDNISOLONE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEOPTERIN; PHENYTOIN; PREDNISOLONE; PROTEIN S100B; RITUXIMAB; TUMOR NECROSIS FACTOR; VALACICLOVIR; S100B PROTEIN, HUMAN;

ADOLESCENT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSKINESIA; EPILEPTIC STATE; FEMALE; FEVER; FOCAL EPILEPSY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFANT; INFLAMMATION; LETHARGY; NEUROIMAGING; NEUROLOGIC DISEASE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE DRUG DOSE; TH1 CELL; TREATMENT DURATION; CASE REPORT; CEREBROSPINAL FLUID; COMPLICATION; MALE; NERVOUS SYSTEM DISEASES; PATHOGENICITY; SIMPLEXVIRUS;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; CHEMOKINES; CHILD, PRESCHOOL; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HUMANS; INFANT; MALE; NERVOUS SYSTEM DISEASES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SIMPLEXVIRUS;

EID: 85018834882     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13431     Document Type: Article

References (29)

1. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014; 29: 90–6.
2. Titulaer MJ, Leypoldt F, Dalmau J. Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis. Mov Disord 2014; 29: 3–6.
3. Jay V, Hwang P, Hoffman HJ, Becker LE, Zielenska M. Intractable seizure disorder associated with chronic herpes infection. HSV1 detection in tissue by the polymerase chain reaction. Childs Nerv Syst 1998; 14: 15–20.
4. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014; 75: 317–23.
5. Aurelius E, Andersson B, Forsgren M, Skoldenberg B, Strannegard O. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infectious Dis 1994; 170: 678–81.
6. Armangue T, Moris G, Cantarin-Extremera V, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015; 85: 1736–43.
7. Lee WJ, Lee ST, Moon J, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 2016; 13: 824–32.
8. Kamei S, Taira N, Ishihara M, et al. Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 2009; 46: 187–93.
9. Hytonen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflamm 2014; 11: 103.
10. Skoldenberg B, Aurelius E, Hjalmarsson A, et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 2006; 253: 163–70.
11. Studahl M, Rosengren L, Gunther G, Hagberg L. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 2000; 247: 636–42.
12. Ygberg S, Fowler A, Wickstrom R. Cytokine and chemokine expression in CSF may differentiate viral and autoimmune NMDAR Encephalitis in children. J Child Neurol 2016; 31: 1450–6.
13. Kothur K, Wienholt L, Tantsis EM, et al. B Cell, Th17, and neutrophil related cerebrospinal fluid cytokine/chemokines are elevated in MOG antibody associated demyelination. PLoS ONE 2016; 11: e0149411.
14. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord 2014; 29: 117–22.
15. Lebon P, Boutin B, Dulac O, Ponsot G, Arthuis M. Interferon gamma in acute and subacute encephalitis. BMJ 1988; 296: 9–11.
16. Vollstedt S, Arnold S, Schwerdel C, et al. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 2004; 78: 3846–50.
17. Wuest TR, Carr DJ. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J Immunol 2008; 181: 7985–93.
18. Brandes M, Legler DF, Spoerri B, Schaerli P, Moser B. Activation-dependent modulation of B lymphocyte migration to chemokines. Int Immunol 2000; 12: 1285–92.
19. Leypoldt F, Hoftberger R, Titulaer MJ, et al. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol 2015; 72: 180–6.
20. Liba Z, Kayserova J, Elisak M, et al. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. J Neuroinflamm 2016; 13: 55.
21. Yamada S, Kameyama T, Nagaya S, Hashizume Y, Yoshida M. Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation. J Neurol Neurosurg Psychiatry 2003; 74: 262–4.
22. Steiner I. Herpes simplex virus encephalitis: new infection or reactivation? Curr Opin Neurol 2011; 24: 268–74.
23. Sellner J, Dvorak F, Zhou Y, et al. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett 2005; 374: 197–202.
24. Lang A, Brien JD, Nikolich-Zugich J. Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens. J Immunol 2009; 183: 8077–87.
25. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005; 76: 1544–9.
26. Ramakrishna C, Openshaw H, Cantin EM. The case for immunomodulatory approaches in treating HSV encephalitis. Future Virol 2013; 8: 259–72.
27. Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 2008; 198: 1002–6.
28. Carr DJ, Chodosh J, Ash J, Lane TE. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 2003; 77: 10037–46.
29. Klimatcheva E, Pandina T, Reilly C, et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol 2015; 16: 6.